Skip to main content

Novel Coronavirus (COVID-19) Information

Just like everywhere else in our nation and the world, things are changing quickly at KU Medical Center. Our leadership teams are continuously evaluating circumstances related to the coronavirus (COVID-19). The Frontiers administrative staff is currently working remotely to allow for social distancing to keep our campus environment safe and to allow our health system partners the space needed to treat patients and focus on their clinical missions.

During this time, please feel free to contact us via phone and email. Our individual contact information can be found on the Administrative Team page. Inquiries may also be directed to frontiers-info@kumc.edu. We will respond as soon as possible. Thank you for understanding.

For more information regarding KUMC's efforts, please visit the KU Medical Center Coronavirus Information Page. Additional information for KU Medical Center employees can be accessed on Coronavirus COVID-19 Resource Center page on the myKUMC intranet site.


Funding Opportunities

NIH/NCATS Notices of Special Interest for COVID-19 Research

The National Center for Advancing Translational Sciences (NCATS) recently issued two notices of special interest that highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes.

NOT-TR-20-011: Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need

NOT-TR-20-012: Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)

The National Institutes of Health (NIH) has also published two Notices of Special Interest (NOSIs) supporting research activities related to the Social, Behavioral, and Economic Impact of COVID-19. Interested applicants are encouraged to apply by the July 10 deadline for funding this fiscal year.

NOT-MD-20-022: Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations

NOT-MH-20-053: Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need

NCATS is interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA Program-supported resources (e.g., advanced scientific instruments, highly-specialized facilities and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics and vaccines. Learn more

Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)

NCATS is interested in projects that repurpose existing drugs or therapeutics that already have begun or completed a Phase I clinical trial. By building upon previous research and development efforts, new uses for existing drugs or therapeutics can be advanced to testing in clinical trials more quickly than starting from scratch. Learn more

American Lung Association COVID-19 and Emerging Respiratory Viruses Research Award

The American Lung Association COVID-19 and Emerging Respiratory Viruses Research Award is for $100,000 per year, for up to two years. The award is intended to support independent investigators with a stellar track record of accomplishment, who have the potential to advance our knowledge of COVID-19 and other novel respiratory viruses with epidemic potential. Applications are due May 30, 2020. Learn more

Other Funding Opportunities

For more funding opportunities related to COVID-19, visit the COVID-19 Funding Opportunities and Award Management page on the KUMC Research Institute website.


Resources for Researchers

As of March 23, 2020, non non-essential research activities can be conducted on campus at KU Medical Center. For questions related to research, please consult the KUMC FAQs for Researchers intranet site for the most up-to-date information. Frontiers Navigators will continue to provide virtual support to researchers and their teams.

Children's Mercy Kansas City has also suspended all Laboratory and non-clinically beneficial Human Subjects Research. Learn more

Other regional institutions and organizations are continuously updating their COVID-19 policies. Please check their respective websites for the most up-to-date information.

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding

National Institute of Allergy and Infectious Diseases Coronavirus Resources for Researchers

OHRP Guidance on COVID-19

Center for Practical Bioethics: Pandemic Resources and Guidance

LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. It is the most comprehensive resource on the subject, providing a central access to over 1700 (and growing) relevant articles in PubMed. The articles are updated daily and are further categorized by different research topics and geographic locations for improved access. https://www.ncbi.nlm.nih.gov/research/coronavirus/

Resources for Working Remotely

Zoom is a web-conferencing software that allows users to schedule and attend online meetings with computers or mobile devices. You can share audio, video, desktop and more with other participants. Zoom Training Resources

Last modified: Jun 08, 2020
ID=x35234